Login to your account

Username *
Password *
Remember Me

[Preprint] Mixing Covid jabs has good immune response, study finds – “The Com-Cov trial looked at the efficacy of either two doses of Pfizer, two of AstraZeneca, or one of them followed by the other. All combinations worked well, priming the immune system

Mixing Covid jabs has good immune response, study finds – BBC Original study (preprint): Safety and Immunogenicity Report from the Com-COV Study – a Single-Blind Randomised Non-Inferiority Trial Comparing Heterologous And Homologous Prime-Boost Schedules with An Adenoviral Vectored and mRNA COVID-19 Vaccine – SSRN Preprints with the Lancet  

The post [Preprint] Mixing Covid jabs has good immune response, study finds – “The Com-Cov trial looked at the efficacy of either two doses of Pfizer, two of AstraZeneca, or one of them followed by the other. All combinations worked well, priming the immune system”. appeared first on Links Medicus.

Perspective | Why no one is sure if Delta is deadlier – “The variants are spreading faster, but they don’t necessarily have incentive to kill more often”.

Analysis: How long does covid-19 immunity last?

How long does covid-19 immunity last? – The BMJ  

The post Analysis: How long does covid-19 immunity last? appeared first on Links Medicus.

COVID-19 vaccines reduce severity, length, viral load for those who still get infected.

COVID-19 vaccine reduces severity, length, viral load for those who still get infected – University of Arizona Health Sciences Original study: Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines – New England Journal of Medicine   Commentary on Twitter The @CDCgov trial to rigorously assess mRNA vaccination suppression of covid infections as […]

The post COVID-19 vaccines reduce severity, length, viral load for those who still get infected. appeared first on Links Medicus.

RCT: Novavax vaccine conferred 89.7% protection against symptomatic SARS-CoV-2 infection and 100% protection against hospitalizations or deaths.

Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine – New England Journal of Medicine Audio interview: Audio Interview: Another New Covid-19 Vaccine – New England Journal of Medicine Related: Opinion | The mRNA vaccines are extraordinary, but Novavax is even better  

The post RCT: Novavax vaccine conferred 89.7% protection against symptomatic SARS-CoV-2 infection and 100% protection against hospitalizations or deaths. appeared first on Links Medicus.

Long COVID or post-acute sequelae of COVID-19 (PASC): An overview of biological factors that may contribute to persistent symptoms.

Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms – Frontiers in Microbiology  

The post Long COVID or post-acute sequelae of COVID-19 (PASC): An overview of biological factors that may contribute to persistent symptoms. appeared first on Links Medicus.

M-A: The utility of the rapid shallow breathing index in predicting successful extubation – “As a stand-alone test, the RSBI has moderate sensitivity and poor specificity for predicting extubation success”.

The Utility of the Rapid Shallow Breathing Index in Predicting Successful Extubation: A Systematic Review and Meta-analysis – CHEST (link to abstract – $ for full-text)  

The post M-A: The utility of the rapid shallow breathing index in predicting successful extubation – “As a stand-alone test, the RSBI has moderate sensitivity and poor specificity for predicting extubation success”. appeared first on Links Medicus.

Should I get my second AstraZeneca dose? Yes, it almost doubles your protection against Delta.

Should I get my second AstraZeneca dose? Yes, it almost doubles your protection against Delta – The Conversation Related: Effectiveness of COVID-19 vaccines against the B.1.617.2 variant – medRxiv  

The post Should I get my second AstraZeneca dose? Yes, it almost doubles your protection against Delta. appeared first on Links Medicus.

Consensus Statement: The role of lung ultrasound in COVID-19 disease.

The role of lung ultrasound in COVID-19 disease – Insights into Imaging  

The post Consensus Statement: The role of lung ultrasound in COVID-19 disease. appeared first on Links Medicus.

Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.

Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome – European Heart Journal  

The post Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome. appeared first on Links Medicus.